Physician profile
John Russell
NPI 1336171206
$81,908.47
in general payments reported to CMS, 2019-2025
7 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $16K · 2021: $6,108 · 2022: $19K · 2023: $15K · 2024: $8,674 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Consulting Fee: $11K · Travel and Lodging: $1,046 · Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,445.00 |
| Consulting Fee | $11,060.00 |
| Travel and Lodging | $1,045.81 |
| Food and Beverage | $482.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $41,219.24 | 2019-2023 | |
| Pfizer INC. | $32,740.26 | 2021-2025 | |
| Glaxosmithkline, LLC. | $6,730.88 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,032.50 | 2020 | |
| Merck Sharp & Dohme LLC | $111.08 | 2019 | |
| Sumitomo Pharma America, INC. | $53.49 | 2025 | Myfembree |
| Modernatx, INC. | $21.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.